PRELIMINARY ANALYSIS ON EFFICACY OF RITONAVIR-BOOSTED NIRMATRELVIR ON DISEASE PROGRESSION AMONG HIGH-RISK HOSPITALISED COVID-19 PATIENTS: A RETROSPECTIVE CASE-CONTROL STUDY

INTRO: Ritonavir-boosted nirmatrelvir has shown efficacy in reducing the rate of hospitalisation and 28-day mortality among unvaccinated populations with COVID-19. The role of Ritonavir-boosted nirmatrelvir among high risk hospitalised COVID-19 patients remained uncertain. Our study aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, S.P., Chuah, C.H., Mak, W.Y., Tan, J.W., Lee, J.N., Bidin, F.N., Leong, K.N., Wong, P.S., Chow, T.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186958/
http://dx.doi.org/10.1016/j.ijid.2023.04.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186958/
http://dx.doi.org/10.1016/j.ijid.2023.04.287

Ejemplares similares